Cargando…
Metformin induces apoptotic cytotoxicity depending on AMPK/PKA/GSK-3β-mediated c-FLIP(L) degradation in non-small cell lung cancer
BACKGROUND: Metformin, a first-line antidiabetic drug, has recently been reported with anticancer activities in various cancers; however, the underlying mechanisms remain elusive. The aim of the present study was to investigate the role of cellular FADD-like IL-1β-converting enzyme (FLICE)-inhibitor...
Autores principales: | Luo, Zhuang, Zhu, Tingting, Luo, Wei, Lv, Yuanyuan, Zhang, Liyan, Wang, Chu, Li, Min, Wu, Wenjuan, Shi, Shaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331071/ https://www.ncbi.nlm.nih.gov/pubmed/30666163 http://dx.doi.org/10.2147/CMAR.S178688 |
Ejemplares similares
-
Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK
por: Ying, Ying, et al.
Publicado: (2017) -
Flipping the dogma – phosphatidylserine in non-apoptotic cell death
por: Shlomovitz, Inbar, et al.
Publicado: (2019) -
Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells
por: Mu, Qian, et al.
Publicado: (2018) -
Metformin Inhibits Expression and Secretion of PEDF in Adipocyte and Hepatocyte via Promoting AMPK Phosphorylation
por: Yang, Shumin, et al.
Publicado: (2013) -
LKB1/AMPK and PKA Control ABCB11 Trafficking and Polarization in Hepatocytes
por: Homolya, László, et al.
Publicado: (2014)